Evidence map›Paper›PMID 23328671›Full record

ReviewCell death & disease2013

Switching cell fate, ncRNAs coming to play.

D Guan, W Zhang, W Zhang, G-H Liu, J C Izpisua Belmonte

Open access · goldAbstract readReview
In one paragraph

Review in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. LINC00152 mediates CD8Journal of molecular histology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Disordered p53-MALAT1 pathway is associated with recurrent miscarriage.The Kaohsiung journal of medical sciences · 2019
    Article
  9. Article
  10. Epigenetics and bone diseases.Genetics research · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Non-coding landscapes of colorectal cancer.World journal of gastroenterology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

D GuanNational Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
W Zhang
W Zhang
G-H Liu
J C Izpisua Belmonte
Chinese Academy of Sciences · CNInstitute of Biophysics · CNSalk Institute for Biological Studies · USUniversity of Iowa · US

Funding

Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasisR00CA158055 · NCI · UNIVERSITY OF IOWA · PI ZHANG, WEIZHOU · 2012 to 2014
$714k
Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasisK99CA158055 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, WEIZHOU · 2011 to 2011
$110k
NCI NIH HHS CA158055NCI NIH HHS K99 CA158055NCI NIH HHS R00 CA158055
6 · The paper itself

Abstract

Cell fate decision is a critical step during physiological development when embryonic stem cells commit to either becoming adult stem cells or somatic cells. Recent advances in reprogramming demonstrate that a similar set of transcription factors (TFs), which are important for maintaining the pluripotent state of stem cells, can also reprogram somatic cells to induced pluripotent stem cells (iPSCs). In addition, trans-differentiation, which entails the use of different sets of defined factors, whereby one type of somatic cell can be directly converted into another and even to cell types from different germ layers has become a parallel widely used approach for switching cell fate. All these progresses have provided powerful tools to manipulate cells for basic science and therapeutic purposes. Besides protein-based factors, non-coding RNAs (ncRNAs), particularly microRNAs and long ncRNAs, are also involved in cell fate determination, including maintaining self-renewal of pluripotent stem cells and directing cell lineage. Targeting specific ncRNAs represents an alternative promising approach to optimize cell-based disease modeling and regenerative therapy. Here we focus on recent advances of ncRNAs in cell fate decision, including ncRNA-induced iPSCs and lineage conversion. We also discuss some underlying mechanisms and implications in molecular pathogenesis of human diseases.

Indexed as

AnimalsCell LineageCell TransdifferentiationCellular ReprogrammingHumansInduced Pluripotent Stem CellsMicroRNAsRegenerative MedicineRNA, UntranslatedTranscription FactorsMicroRNAsRNA, UntranslatedTranscription Factors

Identifiers

PMID23328671
PMCPMC3563984
OpenAlexW2006751864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.